RNA-binding protein LIN28 is a sensitive marker of ovarian primitive germ cell tumours
Department of Pathology, The Affiliated Hospital of Putian University, Putian, Fujian, China. Histopathology
(Impact Factor: 3.45).
09/2011; 59(3):452-9. DOI: 10.1111/j.1365-2559.2011.03949.x
LIN28 is an RNA-binding protein that has been detected in testicular germ cell tumours (GCTs), but its status in ovarian GCTs is unknown. The aim was to determine the immunohistochemical profile of LIN28 in ovarian GCTs.
Immunohistochemistry of LIN28 was performed in 110 primary and 11 metastatic ovarian GCTs. The percentage of tumour cells stained was scored as 0, 1+ (1-30% cells), 2+ (31-60%), 3+ (61-90%), and 4+ (>90%). To determine its specificity, we stained LIN28 in 119 non-GCTs, including 37 clear cell carcinomas. Strong 4+ LIN28 staining was seen in 4/4 (100%) gonadoblastomas, 7/7 (100%) embryonal carcinomas (ECs), and 41/41 (100%) yolk sac tumours (YSTs). Among 39 dysgerminomas, 4+ staining was seen in 37 and 3+ staining in two (strong in 37; mixed weak and strong in two). Twelve of 14 immature teratomas showed variable LIN28 staining (1+ to 4+) in the immature neuroepithelium (weak to strong staining), whereas mature teratomas, carcinoids, struma ovarii and strumal carcinoids were negative. Only 5/117 non-GCTs (1/37 clear cell carcinomas) showed weak to moderate 1-2+ staining.
LIN28 is a sensitive marker for gonadoblastomas, dysgerminomas, ECs, and YSTs. LIN28 can be used to distinguish them from non-GCTs.
Figures in this publication
Available from: Jun Jia
- "Early studies only used positive tumour cell rate as an index to evaluate the sensitivity of Lin28A staining in gonad tumour diagnosis , . In consideration of the varied staining intensity of Lin28A/B among specimens or even in a same carcinoma section, and the diverse effect of different expression levels on patient outcome, we used semi-quantitative scoring including both staining area and intensity to assess the immunostaining. "
[Show abstract] [Hide abstract]
ABSTRACT: Recent studies showed that incomplete cell reprogramming can transform cells into tumour-like cells. Lin28A is associated with fibroblast and sarcoma cell reprogramming, whereas its homologue Lin28B is associated with hematopoietic cell reprogramming. This study aimed to investigate the expression and prognostic difference between Lin28A and Lin28B in oral squamous cell carcinoma (OSCC). Expression level was assessed by immunohistochemistry and staining location was confirmed by immunofluorescence. Prognostic values were analysed and compared by the Kaplan-Meier analysis and uni and multivariate Cox regression models. Besides, in vitro cell assays and in vivo nude mice xenograft were used to demonstrate the influence of increased Lin28B expression in OSCC. Lin28A and Lin28B expression increased in OSCC, and co-expression of Lin28A and Lin28B showed no significant association with patient prognosis. Kaplan-Meier analysis showed that patients with high Lin28B but not Lin28A expression had lower overall survival (OS) rates than those with low Lin28B expression. Further Univariate analysis showed that patients with increased Lin28B expression had shorter disease-free survival (DFS) and shorter OS, while multivariate analysis showed Lin28B overexpression with TNM stage predicted poor prognosis in patients with OSCC. Besides, stable expressing Lin28B in oral cancer cells promoted cell migration, invasion, colony formation, in vivo proliferation and increased the expression of cancer suppressor miRNA let-7 targeted genes IL-6, HMGA2, the EMT markers Snail and Twist, the angiogenesis inducer VEGF, and the apoptosis inhibitor Survivin. These combined results indicate that Lin28B is a novel marker for predicting prognosis in patients with OSCC and may be a therapeutic target.
PLoS ONE 12/2013; 8(12):e83869. DOI:10.1371/journal.pone.0083869 · 3.23 Impact Factor
Available from: sciencedirect.com
- "da et al . , 2013 ) . Interestingly , aberrant overex - pression of Lin28a and Lin28b is associated with the malignancy of human germ cell tumors , such as choriocarcinomas , embry - onal carcinomas , seminomas , yolk sac tumors , and mixed germ cell tumors ( West et al . , 2009 ; Cao et al . , 2011a ; Cao et al . , 2011b ; Gillis et al . , 2011 ; Xue et al . , 2011 ) . Overexpression of Lin28a produces higher - grade teratomas , whereas Lin28a knockdown leads to smaller teratomas , suggesting that Lin28a acts as an oncogene in germ cell tumors by enhancing the self - renewal of PGCs and spermatogonial stem cells ( West et al . , 2009 ) . Although Lin28a and Lin28b decline rapidly upon implantation"
[Show abstract] [Hide abstract]
ABSTRACT: In recent years, the highly conserved Lin28 RNA-binding proteins have emerged as factors that define stemness in several tissue lineages. Lin28 proteins repress let-7 microRNAs and influence mRNA translation, thereby regulating the self-renewal of mammalian embryonic stem cells. Subsequent discoveries revealed that Lin28a and Lin28b are also important in organismal growth and metabolism, tissue development, somatic reprogramming, and cancer. In this review, we discuss the Lin28 pathway and its regulation, outline its roles in stem cells, tissue development, and pathogenesis, and examine the ramifications for re-engineering mammalian physiology.
Cell stem cell 04/2013; 12(4):395-406. DOI:10.1016/j.stem.2013.03.005 · 22.27 Impact Factor
Available from: Min-Ju Kang
[Show abstract] [Hide abstract]
ABSTRACT: Senescence represents a state of indefinite growth arrest in cells that have reached the end of their replicative life span, have become damaged, or express aberrant levels of cancer-related proteins. While senescence is widely considered to represent a tumor-suppressive mechanism, the accumulation of senescent cells in tissues of older organisms is believed to underlie age-associated losses in physiologic function and age-related diseases. With the emergence of microRNAs (miRNAs) as a major class of molecular regulators of senescence, we review the transcriptional and post-transcriptional factors that control senescence-associated microRNA biosynthesis. Focusing on their enhancement or repression of senescence, we describe the transcription factors that govern the synthesis of primary (pri-)miRNAs, the proteins that control the nuclear processing of pri-miRNAs into precursor (pre-)miRNAs, including RNA editing enzymes, RNases, and RNA helicases, and the cytoplasmic proteins that affect the final processing of pre-miRNAs into mature miRNAs. We discuss how miRNA biogenesis proteins promote or inhibit senescence, and thus influence the senescent phenotype that affects normal tissue function and pathology.
Ageing research reviews 01/2012; 11(4):491-500. DOI:10.1016/j.arr.2012.01.003 · 4.94 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.